Sponsor or institution
Clinical trials and research at Gigamune, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $1.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new lentivector to deliver multiple TCRs for melanoma cell therapy
A new gene-delivery approach aims to boost T cell receptors inside patients’ own cells to treat advanced melanoma.
-
Gene therapy for sickle cell disease using a new viral approach
This study is testing a new gene therapy that uses a special delivery system to help people with sickle cell disease and β-thalassemia make healthy red blood cells, aiming to offer a long-lasting cure without the need for complicated hospital treatments.
-
Delivering a complete dystrophin protein to muscle cells for treating Duchenne muscular dystrophy.
This study is exploring a new gene therapy that aims to help people with Duchenne muscular dystrophy by delivering a complete version of a protein called dystrophin to their muscle cells, which could improve muscle function and health.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.